The Public Needs to Know



The Public Needs to Know

Introduction

This is an informative white paper that is aimed at addressing issues related to the development of drugs business for patients of cancer disease. The paper has strived to cover four key areas to highlight the significance of the matter. It has focused on the economic situation of the country that may or may not be in favor of this business. It has made an attempt to highlight special needs of the current population who is exposed to this dangerous disease.

The paper also strives to outline the process that may be undergone to implement an effective drug strategy with related benefits of the proposed program. The paper is also comprised of two visuals that help to illustrate the issue and significance of the proposed program. The thesis statement for this paper is that cancer is now curable on an affordable cost with developments in the field that diagnose the disease at an early stage.

Discussion

The scenario selected for this informative white paper is related to that portion of the population which is affected by dangerous disease of cancer. It proposes a drug program that might be helpful to address special needs of this segment of the population.

Cancer could be stated as a health killer that can be associated with many health issues in the human body. Statistics indicate that in 2007 around 7.6 million deaths were caused by cancer on a global scale, which is being equivalent to around 13% of human deaths in totality (Wilking & Jonsson, 2011). The traditional oncological methods of treating cancer have failed to prevent the progress of the disease. However, scientists have come up with new cancer drugs that can change the situation. There are many big firms of the US drug industry who have poured their money into clinical trials to curb the disease and make it curable. The industry statistics for the year 2010 reflect the situation as below (The Economist, 2011):

Figure 01: Health issues raised by Cancer (The Economist, 2011)

Since prevalence of cancer is among all age groups that have been silent killing for past several years, new drugs for cancer have been developed to cure cancer and help patients live a carefree, healthy and prolonged life. In the US, treatment for cancer ranges from affordable and economic treatments to costly and unaffordable medication and treatment process (Wilking & Jonsson, 2011).

According to estimates the annual ...